Cargando…

Humans as holobionts: implications for prevention and therapy

The human gut microbiota is increasingly recognized for its important or even decisive role in health. As it becomes clear that microbiota and host mutually affect and depend on each other in an intimate relationship, a holistic view of the gut microbiota–host association imposes itself. Ideally, a...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Guchte, Maarten, Blottière, Hervé M., Doré, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928587/
https://www.ncbi.nlm.nih.gov/pubmed/29716650
http://dx.doi.org/10.1186/s40168-018-0466-8
_version_ 1783319269229985792
author van de Guchte, Maarten
Blottière, Hervé M.
Doré, Joël
author_facet van de Guchte, Maarten
Blottière, Hervé M.
Doré, Joël
author_sort van de Guchte, Maarten
collection PubMed
description The human gut microbiota is increasingly recognized for its important or even decisive role in health. As it becomes clear that microbiota and host mutually affect and depend on each other in an intimate relationship, a holistic view of the gut microbiota–host association imposes itself. Ideally, a stable state of equilibrium, homeostasis, is maintained and serves health, but signs are that perturbation of this equilibrium beyond the limits of resilience can propel the system into an alternative stable state, a pre-disease state, more susceptible to the development of chronic diseases. The microbiota–host equilibrium of a large and growing proportion of individuals in Western society may represent such a pre-disease state and explain the explosive development of chronic diseases such as inflammatory bowel disease, obesity, and other inflammatory diseases. These diseases themselves represent other alternative stable states again and are therefore hard to cure. The holistic view of the microbiota–host association where feedback loops between microbiota and host are thought to maintain the system in a stable state—be it a healthy, pre-disease, or disease state—implies that integrated approaches, addressing host processes and microbiota, should be used to treat or prevent (pre-)disease.
format Online
Article
Text
id pubmed-5928587
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59285872018-05-09 Humans as holobionts: implications for prevention and therapy van de Guchte, Maarten Blottière, Hervé M. Doré, Joël Microbiome Commentary The human gut microbiota is increasingly recognized for its important or even decisive role in health. As it becomes clear that microbiota and host mutually affect and depend on each other in an intimate relationship, a holistic view of the gut microbiota–host association imposes itself. Ideally, a stable state of equilibrium, homeostasis, is maintained and serves health, but signs are that perturbation of this equilibrium beyond the limits of resilience can propel the system into an alternative stable state, a pre-disease state, more susceptible to the development of chronic diseases. The microbiota–host equilibrium of a large and growing proportion of individuals in Western society may represent such a pre-disease state and explain the explosive development of chronic diseases such as inflammatory bowel disease, obesity, and other inflammatory diseases. These diseases themselves represent other alternative stable states again and are therefore hard to cure. The holistic view of the microbiota–host association where feedback loops between microbiota and host are thought to maintain the system in a stable state—be it a healthy, pre-disease, or disease state—implies that integrated approaches, addressing host processes and microbiota, should be used to treat or prevent (pre-)disease. BioMed Central 2018-05-01 /pmc/articles/PMC5928587/ /pubmed/29716650 http://dx.doi.org/10.1186/s40168-018-0466-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
van de Guchte, Maarten
Blottière, Hervé M.
Doré, Joël
Humans as holobionts: implications for prevention and therapy
title Humans as holobionts: implications for prevention and therapy
title_full Humans as holobionts: implications for prevention and therapy
title_fullStr Humans as holobionts: implications for prevention and therapy
title_full_unstemmed Humans as holobionts: implications for prevention and therapy
title_short Humans as holobionts: implications for prevention and therapy
title_sort humans as holobionts: implications for prevention and therapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928587/
https://www.ncbi.nlm.nih.gov/pubmed/29716650
http://dx.doi.org/10.1186/s40168-018-0466-8
work_keys_str_mv AT vandeguchtemaarten humansasholobiontsimplicationsforpreventionandtherapy
AT blottierehervem humansasholobiontsimplicationsforpreventionandtherapy
AT dorejoel humansasholobiontsimplicationsforpreventionandtherapy